We have demonstrated the feasibility of imaging mouse brain metabolism using photoacoustic computed tomography (PACT), a fast, noninvasive and functional imaging modality with optical contrast and acoustic resolution. Brain responses to forepaw stimulations were imaged transdermally and transcranially. 2-NBDG, which diffuses well across the blood-brain-barrier, provided exogenous contrast for photoacoustic imaging of glucose response. Concurrently, hemoglobin provided endogenous contrast for photoacoustic imaging of hemodynamic response. Glucose and hemodynamic responses were quantitatively decoupled by using two-wavelength measurements. We found that glucose uptake and blood perfusion around the somatosensory region of the contralateral hemisphere were both increased by stimulations, indicating elevated neuron activity. While the glucose response area was more homogenous and confined within the somatosensory region, the hemodynamic response area had a clear vascular pattern and spread wider than the somatosensory region. Our results demonstrate that 2-NBDG-enhanced PACT is a promising tool for noninvasive studies of brain metabolism.
Introduction
In mammals, the brain performs numerous computation-intensive tasks such as information processing, perception, motor control and learning, and thus consumes a large amount of energy in proportion to its volume. For example, humans devote 20-25% of their metabolism to the brain, where the energy is mostly used for sustaining the electric charge (membrane potential) of neurons (Mink et al., 1981) . In humans and many other species, the brain gets most of its energy from oxygen-dependent metabolism of glucose (Coghill et al., 1994; Fox and Raichle, 1986; Gjedde et al., 2002; Hall et al., 2012; Smith et al., 2009 ). An abnormal metabolic rate of glucose and/or oxygen usually reflects a diseased status of the brain, such as cancer or Alzheimer's disease (Fulham et al., 1992; Mosconi et al., 2009 ). In addition, physiologically active regions of the cerebral cortex consume more energy than inactive regions (Raichle and Gusnard, 2002) . These phenomena have formed the basis for functional brain imaging methods, including positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) (Mehagnoul-Schipper et al., 2002; Schlemmer et al., 2008) .
However, PET depends on the administration of radioactively-labeled tracers (e.g., 2-deoxy-2-fluoro-D-glucose, FDG), a complex procedure with exposure to ionizing radiation. fMRI is primarily sensitive to deoxy-hemoglobin and suffers from slow imaging speed. Moreover, both PET and fMRI are expensive techniques with poor spatial resolutions. Therefore, a fast, noninvasive and non-ionizing imaging modality with good spatial resolutions is needed to advance metabolism-associated studies of brain physiology and pathology.
On the basis of the photoacoustic effect, photoacoustic tomography (PAT) solves the resolution drawback of pure optical imaging and the contrast drawback of pure ultrasonic imaging (Wang and Hu, 2012; Wang, 2008 Wang, , 2009a . In PAT, photon energy absorbed by molecules is partially or completely converted into heat, which thermoelastically induces pressure waves. The induced pressure waves are detected by ultrasonic detectors to form an image (Wang and Hu, 2012) . PAT is capable of anatomical, functional, molecular and metabolic imaging of small animals, with highly scalable spatial resolution and penetration depth (Wang, 2009a (Wang, , 2009b Zhang et al., 2006) . Photoacoustic computed tomography (PACT) is a major implementation of PAT, which aims at fast data acquisition, sub-millimeter resolution and deep penetration depth beyond the optical diffusion limit (Li et al., 2008 (Li et al., , 2010 Wang et al., 2003; Xia et al., 2011) . Noninvasive, label-free and functional PACT of the rat brain was demonstrated by accurately mapping brain lesions and cerebral hemodynamics (Wang et al., 2003) . Molecular imaging of a mouse brain tumor in vivo was also performed with PACT, using IRDye-800-c as the contrast agent (Li et al., 2008) .
Here, for the first time, we have demonstrated that PACT is able to image glucose uptake in the mouse brain, using a newly developed glucose analog 2-deoxy-2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-D-glucopyranose (2-NBDG). To demonstrate the metabolic imaging capability of PACT, we studied in vivo forepaw stimulation responses. Our phantom and animal studies showed that PACT could spectrally separate 2-NBDG and blood using two-wavelength measurements, thus decouple the glucose and hemodynamic responses to the stimulations. Open-scalp photoacoustic microscopy and fluorescence imaging were used to validate the results from PACT.
Materials and methods

2-NBDG
2-NBDG is a newly developed fluorescent 2-deoxyglucose (2-DG) analog (Bem et al., 2007; Cheng et al., 2006; Gaudreault et al., 2008; Itoh et al., 2004; Langsner et al., 2011; Millon et al., 2011; O'Neil et al., 2005; Sheth et al., 2009; Tsytsarev et al., 2012) . Like the FDG (molecular weight: 181) used in PET studies, 2-NBDG is transported into cells via the same GLUT as glucose (Sheth et al., 2009 ). Once taken up by the cells, 2-NBDG is phosphorylated to 2-NBDG-6-P, which prevents it from being released again from the cells. However, because of the lack of the 2-hydroxyl group needed for glycolysis, 2-NBDG-6-P cannot be further metabolized. Therefore, the distribution of trapped 2-NBDG is a good reflection of glucose metabolism (O'Neil et al., 2005) . Because 2-NBDG is a relatively small molecule (molecular weight: 342) [ Fig. 1a] , it crosses the blood-brain-barrier much more easily than other near-infrared fluorophore-labeled 2-DG analogs, such as IRDye800-DG (molecular weight: 1330) (Cheng et al., 2006; Itoh et al., 2004) . Moreover, 2-NBDG has its peak absorption at 478 nm, where hemoglobin has a much lower absorption than at the peak absorbing wavelength [ Fig. 1b] . As a result, the signal contribution from hemoglobin can be neglected at this wavelength. These features have made 2-NBDG particularly suitable for brain studies.
Noninvasive photoacoustic computed tomography (PACT) Fig. 2a is the schematic of the PACT setup. An OPO laser (BasiScan 120, Spectra-Physics) is pumped by an Nd:YAG laser (Brilliant B, Quantel) with a third harmonic generator (355 nm) to provide pulses with wavelengths tunable from 420 nm to 680 nm. The pulse duration is 6 ns, and the pulse repetition rate is 10 Hz. The laser beam is homogenized by an optical diffuser (EDC-5, RPC Photonics) to provide uniform illumination over the mouse brain. The maximum light intensity at the tissue surface is approximately 10 mJ/cm 2 , below the ANSI limit at the chosen wavelengths. The photoacoustic signals are detected by a 5 cm diameter full-ring ultrasonic transducer array with 512 elements (Imasonic, Inc.). The central frequency of the ultrasonic transducer array is 5 MHz, and the 6-dB bandwidth is more than 80%. Each element in the array is directly shaped into an arc to produce an axial focal depth of 19 mm. The combined foci of all elements form a relatively uniform imaging region of 20 mm diameter and 1 mm thickness. Within this region, the axial (radial) resolution is 0.10 mm, and the transverse (tangential) resolution is 0.25 mm (Gamelin et al., 2009) . As shown in Fig. 2b , after a complete data acquisition from all 512 elements, the raw data is reconstructed to form a photoacoustic image of the brain based on the universal back-projection algorithm (Xu and Wang, 2007) . The imaging speed of the current system is 1.6 s per frame.
Optical-resolution photoacoustic microscopy (OR-PAM)
OR-PAM, another implementation of PAT, aims at capillary-level resolution within the optical diffusion limit (Hu et al., 2011; Maslov et al., 2008; Wang, 2010, 2011; Yao et al., 2009 . As shown in Fig. 2c , by focusing the laser pulses to a diffraction-limit spot using an objective with an NA of 0.1 (AC127-050-A, Thorlabs), OR-PAM achieves a transverse resolution of 5 μm. By using a single-element ultrasonic transducer with a central frequency of 50 MHz and a 6-dB bandwidth of 100% (V214-BB-RM, Olympus-NDT), OR-PAM achieves an axial resolution of 15 μm. Due to scattering by the tissue, the penetration depth of OR-PAM is limited to~1 mm, which is sufficient for transcranial imaging of the cerebral cortex but not transdermal imaging. The arrival time of the PA signal provides depth information, and volumetric imaging is acquired by two-dimensional raster scanning of the sample. In this study, to validate the cortical vascular image obtained by PACT, the same mouse was imaged by OR-PAM at 570 nm after the PACT imaging. The scalp was surgically removed, while the skull was left intact. It took about 30 min to acquire an OR-PAM image over a 5 × 10 mm 2 area.
Fluorescence imaging
To confirm the stimulation induced changes in 2-NBDG uptake in the brain, open-scalp fluorescence imaging using the same experimental protocol was performed on a different mouse. The fluorescence imaging system shown in Fig. 2d has been reported previously (Tsytsarev et al., 2012) . Briefly, the light source is a 120-watt xenon arc lamp (Oriel Inc.) with an excitation filter (450 ± 20 nm, FB450-40, Thorlabs). Fluorescence images are captured by a low-noise CCD camera (Meade Inc.). An emission filter (550 ± 20 nm, FB550-40, Thorlabs) and an achromatic doublet (NT45-265, Edmund) comprise the camera lens. In this study, the fluorescence images were acquired with a CCD exposure time of 0.5 s. Whitelight images were acquired with a CCD exposure time of 0.05 s after removing the emission filter and turning on the room light.
Because blood vessels appeared darker than the background in the white-light images, the image intensity was reversed for better clarity.
Animal preparation
Female ND4 Swiss Webster mice (Harlan Laboratory, 16 to 20 g) were used for the current study. The laboratory animal protocols for this work were approved by the Animal Studies Committee of Washington University in St. Louis. To enhance 2-NBDG uptake, the mice were fast for 24 h before the experiment (Sheth et al., 2009 ). Before imaging, the hair on each mouse's head was removed with a depilatory. An intraperitoneal dose of 90 mg/kg ketamine plus 10 mg/kg xylazine was used for anesthesia. The mouse was then taped to a lab-made animal holder, which was then mounted to the PACT system. Instead of being fully immersed in water, the animal was supported from below, with the head being covered by a flexible membrane. The entire experiment took less than one hour, therefore additional injection of the anesthetic mixture was not needed. The animal preparation for OR-PAM and fluorescence imaging was similar, except that there was no water coupling for fluorescence imaging. Three mice were used for PACT and subsequent OR-PAM imaging, and one mouse was used for fluorescence imaging.
Forepaw stimulation
Thirty minutes after the injection of 0.3 mL 3 mM 2-NBDG via the tail vein, stimulations were introduced by two pairs of needle electrodes inserted under the skin of the right and left forepaws, respectively. The electrodes were connected to a function generator (DS345, Stanford Research Systems) through a manual switch. The whole procedure consisted of four periods, each lasting for 3 min [ Fig. 3a] . The first and third periods (P 1 and P 3 ) were resting states, while the second period (P 2 ) was right paw stimulation (RPS) and the fourth period (P 4 ) was left paw stimulation (LPS). Each stimulation period consisted of a train of electrical pulses with an amplitude of 2 mA, a pulse width of 0.25 s and a repetition rate of 2 Hz [ Fig. 3b ]. PACT acquired images continuously through the four periods. The procedure was first performed for 12 min at 478 nm and then repeated for 12 min at 570 nm after a pause of 10 min. We assumed that brain responses were repeatable within the time window of the experiment.
Image co-registration
Before quantitative analysis, the PA images at 570 nm from OR-PAM and PACT were co-registered by using the MATLAB Image Processing Toolbox (R2010b, Mathworks, Boston, MA). Here, a 2D rigid registration was performed, which included linear translation, scaling, and rotation. The first step was to manually select 10-20 control points in the two images. The spatial translation, scaling and rotation matrix was computed based on the coordinates of these control points. The entire OR-PAM image was then transformed and registered to the PACT image using this matrix. To show the co-registration performance, the coregistered OR-PAM image was superimposed on top of the PACT image, with the overlay transparency proportional to the OR-PAM image pixel values.
Signal processing
In PACT, for both phantom and in vivo studies, the images acquired at 478 nm and 570 nm were used to reconstruct the distribution of 2-NBDG and hemoglobin, respectively. Since deoxy-and oxy-hemoglobin have the same absorption coefficients at 570 nm, the PA signal amplitude was proportional to the total hemoglobin concentration C Hb , an index for blood perfusion.
For open-scalp OR-PAM, because the mouse skull is translucent, the attenuation of light due to the skull was neglected. The laser fluence measured at the skull surface is a good approximation of the actual fluence at the blood vessels. Therefore, C Hb can be estimated as (Wang and Wu, 2007) 
Here, the subscript OR denotes the OR-PAM system and the superscript 570 denotes the wavelength. k OR is a calibration factor measured from blood in a clear medium, which incorporates the system detection efficiency and Grueneisen coefficient. ε Hb 570 is the molar extinction coefficient of hemoglobin at 570 nm, F OR 570 is the laser fluence at the skull surface, and V OR 570 is the OR-PAM signal amplitude.
Because PACT shares the same absorption contrast as OR-PAM, the calibrated C Hb from OR-PAM can be directly transferred to PACT once the images from the two systems are co-registered. We estimate the calibration factor k CT for PACT by
Here, the subscript CT denotes the PACT system. F CT 570 is the laser fluence measured at the scalp surface and V CT 570 is the PACT signal amplitude. In addition to the system detection efficiency and Grueneisen coefficient, k CT also incorporates an attenuation factor of the laser fluence at 570 nm, which cannot be neglected in PACT owing to the scalp. The fluence attenuation of the scalp is wavelength dependent. However, the effective attenuation coefficients of the nude mouse scalp at 478 nm (7.1 cm −1 ) and 570 nm (6.5 cm
) are approximately the same (Smith et al., 2009) , and the mouse scalp is relatively thin (less than 1.5 mm) (Azzi et al., 2005) . Therefore, the fluence attenuations at the two wavelengths were treated as the same. We also assumed that the heterogeneity of the scalp was negligible. Accordingly, we can estimate the 2-NBDG concentration C 2 − NBDG as
Here, ε 2 − NBDG 478 is the molar extinction coefficient of 2-NBDG at 478 nm. η 2 − NBDG is the conversion efficiency from absorbed optical energy to heat, which is 45% for 2-NBDG (Natarajan and Srienc, 1999) . The conversion efficiency for hemoglobin is absent in Eq. (2) because it is 100%.
Eqs.
(1)-(3) can be used to estimate the absolute concentrations of hemoglobin and 2-NBDG in the brain. Because the absolute baseline signals vary across the brain, relative changes are more robust for quantifying the responses induced by stimulations. However, it is also important to demonstrate the absolute imaging capability of PACT, which is useful for the baseline mapping. In addition, future quantifications of the metabolic rates of oxygen and glucose require knowledge of the absolute concentrations.
In forepaw stimulations, PACT images acquired during each period (P 1-4 ) were averaged at each wavelength to increase the signal-to-noise ratio. The relative changes were computed as (P 2 −P 1 )/P 1 for RPS, and as (P 4 −P 3 )/P 3 for LPS. Only pixels with amplitude above 1.5 times the noise level were used for calculation. In response quantifications, only pixels with response magnitude above 10% of the maximum magnitude were averaged. The same procedure was also applied to the fluorescence imaging results.
Response areas at the two wavelengths were also quantified. Here, the response area was defined by the pixels with a response magnitude above 10% of the maximum response magnitude. The cortical area covered by the responding vessels was estimated as well. An ellipse was used to fit the outline of the responding vessels, with the center, major axis, minor axis and orientation being the fitting variables. The area of the best fit ellipse was approximated as the covered area.
Results
PACT of 2-NBDG and blood phantom
A phantom study was first performed to validate the spectral separation of 2-NBDG and blood. As shown in Fig. 4a , whole bovine blood (hemoglobin concentration: 2.5 mM) and 0.4 mM 2-NBDG solution were embedded in gelatin and imaged by PACT at 478 nm and 570 nm. This 2-NBDG concentration was close to the estimated 2-NBDG concentration in animal studies to be performed later. The ratios between the averaged PA signal amplitudes of 2-NBDG and blood at 478 nm and 570 nm were 9:1 and 0.06:1, respectively [ Fig. 4b ]. Blood was almost invisible at 478 nm, so was 2-NBDG at 570 nm. The PA amplitude of the 2-NBDG sample happened to be nearly identical to (0.98 times) that of the blood sample at 570 nm. Therefore, 2-NBDG and blood could be separated as shown in Fig. 4c . In addition, we found that 2-NBDG was more diffusive than hemoglobin (molecular weight: 64,458) in gelatin, due to the much smaller size of 2-NBDG molecules.
PACT of mouse brain
Figs. 4e-f are noninvasive PACT images of a mouse brain, acquired 30 min after 2-NBDG administration. At 478 nm, the PA signal amplitudes reflected the 2-NBDG concentration in the brain tissue [ Fig. 4e] . At 570 nm, the PA signal amplitudes reflected the total hemoglobin concentration in blood vessels [ Fig. 4f ]. Cortical vascular landmarks including the sagittal sinus (SS) and coronal suture (CS) were clearly imaged by PACT and confirmed by open-scalp photography. A merged image of C Hb and C 2-NBDG is shown in Fig. 4g , where 2-NBDG signals from blood vessels were excluded. The hemoglobin distribution was superimposed on top of the 2-NBDG distribution, with the transparency of the hemoglobin layer proportional to its pixel values. Capillary-level OR-PAM images of the same mouse are shown in Figs 
PACT of cortical responses to forepaw stimulations
Figs. 6a-b are the relative changes of PA signals induced by forepaw stimulations. At 478 nm [ Fig. 6a] , the RPS and LPS caused PA signal amplitudes to increase by 3.6%± 2.2% and 2.0%± 1.1% in the somatosensory region (SR) of the contralateral hemisphere, respectively.
Such increases indicate elevated glucose uptake rates, and thus reflect increased neuron activity. Under the two stimulations, the response areas were 5.7± 1.3 mm 2 and 7.4 ±2.5 mm 2 , respectively. Similarly, at 570 nm [ Fig. 6b] , the RPS and LPS caused PA signal amplitudes to increase by 6.4%± 5.3% and 3.2% ± 2.9% in the contralateral hemisphere, respectively. Such changes indicate an increase in total hemoglobin concentration arising from elevated inflows of fresh blood, and thus reflect increased neuron activity as well. Under the two stimulations, the response areas were 4.7± 1.5 mm 2 and 4.5 ± 1.2 mm 2 , respectively. Furthermore, the responding vessels covered much larger cortical regions of 16.5 ± 3.3 mm 2 and 15.1± 2.5 mm 2 , respectively, as shown in Fig. 7a . The areas covered by the responding vessels were significantly wider than the 2-NBDG response areas for both RPS and LPS, with p values less than 0.05 (Fig. 7b) .
In addition, the linear regression shows that the 2-NBDG response amplitude was approximately proportional to that of the hemoglobin response for both RPS and LPS, with ratios of~0.48 and~0.52, respectively (Fig. 8a) . Similarly, the ratios between the 2-NBDG response area and the area covered by the responding vessels were~0.41 and~0.57 for RPS and LPS, respectively (Fig. 8b) . The high correlation of the two responses may reflect the close coupling between oxygen metabolism and glucose metabolism in the brain.
Fluorescence imaging of cortical responses to forepaw stimulations
First, whole bovine blood and 2-NBDG (0.4 mM) were enclosed in 1 mm diameter glass tubes and imaged by our fluorescence setup [ Fig. 9a ]. The fluorescence image shows that blood did not generate fluorescence while 2-NBDG did profusely.
Second, using the same experimental protocol as in PACT, we imaged the cortical responses to forepaw stimulations on a different mouse using the fluorescence setup. The results are shown in Fig. 9b . While the white light image shows the detailed cortical vasculature, the fluorescence image shows the 2-NBDG distribution and thus the glucose metabolism. The RPS and LPS induced fluorescence intensity to increase by 5.1% and 6.2% in the SR of the contralateral hemisphere, respectively. Such increases indicate elevated glucose uptakes in the SR, which qualitatively agree with the glucose responses assessed by PACT.
Discussion
The pathways of oxygen metabolism and glucose metabolism are closely coupled in neuron activity. One of the potential uses of PACT is the label-free measurement of metabolic rate of oxygen (MRO 2 ) (Wang, 2008; . Currently, except for blood flow speed, PACT can measure all the other parameters required for quantifying MRO 2 , namely vessel cross-section, oxygen saturation and total concentration of hemoglobin, and tissue volume. Recently, a few PA methods have been proposed for blood flow measurement in deep tissue, which may be applicable to PACT (Brunker and Beard, 2010; Fang et al., 2007; Sheinfeld and Eyal, 2012; Sheinfeld et al., 2010) . Therefore, PACT has the potential to simultaneously image the two metabolic pathways: oxygen metabolism as described by others, and glucose metabolism as shown in this paper.
Previous studies by PET and fMRI have shown that forepaw stimulations can increase the cerebral metabolic rate of oxygen (CMRO 2 ) (Liu et al., 2004; Mandeville et al., 1998; Ogawa et al., 1994) . Because the blood oxygenation change is much smaller than the blood flow change, such an increase in CMRO 2 is mainly attributed to the elevated blood perfusion (Liu et al., 2004; Mandeville et al., 1998; Ogawa et al., 1994) . In our results, the intensified photoacoustic signal at 570 nm provided a direct evidence of the increase in blood perfusion. For absolute CMRO 2 quantification, our future work will incorporate multiwavelength measurement of oxygenation.
In addition, we found that the glucose response area was confined within the SR, while the hemodynamic response area was much larger than that. Glucose response was a focal activity restricted to The p values were calculated from paired Student's t-test between stimulated states P 2 or P 4 and resting states P 1 or P 3 .
neurons responsible for the stimulated site. In contrast, hemodynamic response was less spatially restricted since fresh blood must be delivered from the major feeding arteries, through the capillaries of the SR, to the major draining veins. Moreover, the hemodynamic response may spread into neighboring vessels of the same vascular network.
Except for the dimensional discrepancy, the glucose response area was more homogenous than the hemodynamic response area. The latter was characterized by a strong vascular pattern. Moreover, there was a clear core for the glucose response, which is indicated by the double arrows in Fig. 6a . Such a core was not seen in the hemodynamic response. This again suggests that glucose response was a focal activity. The core region contained the neurons most sensitive to the stimulated site.
In summary, using 2-NBDG as the exogenous contrast and hemoglobin as the endogenous contrast, we have demonstrated that PACT is capable of imaging the metabolic response of a mouse brain to forepaw stimulations. As a quantitative imaging modality, PACT can spectrally separate 2-NBDG and hemoglobin by virtue of its optical absorption contrast. As a fast imaging modality, PACT can acquire a volumetric image in less than two seconds with a laser repetition rate of 10 Hz. This imaging speed can be further improved by a laser system with higher repetition rate and automatic wavelength switch. As a deep imaging modality, PACT can transdermally and transcranially localize the spatial patterns of the brain responses by virtue of its high ultrasonic resolution. With all these merits, we expect PACT to be applied to more brain metabolism studies in the future. Fig. 7 . Quantification of the cortical region covered by responding vessels. (a) An ellipse was used to fit the outline of the responding vessels, with the center, major axis, minor axis and orientation being the fitting variables. (b) Quantification of hemoglobin response area, 2-NBDG response area and cortical region covered by responding vessels, averaged over three mice. Error bars: standard deviation. The p values were calculated from paired Student's t-test between the 2-NBDG response area and the cortical region covered by responding vessels. 
